Real versus virtual phenotype to guide treatment in heavily pretreated patients: 48-week follow-up of the Genotipo-Fenotipo di Resistenza (GenPheRex) trial.

Source:http://linkedlifedata.com/resource/pubmed/id/12626886

J. Acquir. Immune Defic. Syndr. 2003 Mar 1 32 3 268-80

Download in:

View as

Triples

General Info

PMID
12626886